Recombinant multi-species EHMT1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine EHMT1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene is a histone methyltransferase that methylates the lysine-9 position of histone H3. This action marks the genomic region packaged with these methylated histones for transcriptional repression. This protein may be involved in the silencing of MYC- and E2F-responsive genes and therefore could play a role in the G0/G1 cell cycle transition. Defects in this gene are a cause of chromosome 9q subtelomeric deletion syndrome (9q-syndrome, also known as Kleefstra syndrome). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2017]
The Alternative Names of target: 9230102N17Rik,D330003E03,EHMT1,EHMT1-IT1,EUHMTASE1,Ehmt1,Eu-HMTase1,Euchromatic histone-lysine N-methyltransferase 1 (Eu-HMTase1),FP13812,G9a-like protein 1 (GLP,GLP,GLP1,GLP1),Histone H3-K9 methyltransferase 5 (H3-K9-HMTase 5),Histone-lysine N-methyltransferase EHMT1,KLEFS1,KMT1D,Lysine N-methyltransferase 1D,mKIAA1876

Target products collectionGo to EHMT1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T39996-Ag-1/ GM-Tg-hg-T39996-Ag-2 Human EHMT1 protein Human
GM-Tg-rg-T39996-Ag-1/ GM-Tg-rg-T39996-Ag-2 Rat EHMT1 protein Rat
GM-Tg-mg-T39996-Ag-1/ GM-Tg-mg-T39996-Ag-2 Mouse EHMT1 protein Mouse
GM-Tg-cynog-T39996-Ag-1/ GM-Tg-cynog-T39996-Ag-2 Cynomolgus/Rhesus macaque EHMT1 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-T39996-Ag-1/ GM-Tg-felg-T39996-Ag-2 Feline EHMT1 protein Feline
GM-Tg-cang-T39996-Ag-1/ GM-Tg-cang-T39996-Ag-2 Canine EHMT1 protein Canine
GM-Tg-bovg-T39996-Ag-1/ GM-Tg-bovg-T39996-Ag-2 Bovine EHMT1 protein Bovine
GM-Tg-equg-T39996-Ag-1/ GM-Tg-equg-T39996-Ag-2 Equine EHMT1 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T39996-Ag-1/ GM-Tg-hg-T39996-Ag-2; GM-Tg-rg-T39996-Ag-1/ GM-Tg-rg-T39996-Ag-2;
GM-Tg-mg-T39996-Ag-1/ GM-Tg-mg-T39996-Ag-2; GM-Tg-cynog-T39996-Ag-1/ GM-Tg-cynog-T39996-Ag-2;
GM-Tg-felg-T39996-Ag-1/ GM-Tg-felg-T39996-Ag-2; GM-Tg-cang-T39996-Ag-1/ GM-Tg-cang-T39996-Ag-2;
GM-Tg-bovg-T39996-Ag-1/ GM-Tg-bovg-T39996-Ag-2; GM-Tg-equg-T39996-Ag-1/ GM-Tg-equg-T39996-Ag-2
Products Name EHMT1 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name EHMT1
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine EHMT1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.